30

Shanghai Universal Biotech Co LtdSHE 301166 Stock Report

Last reporting period 30 Sep, 2023

Updated 11 Nov, 2024

Last price

Market cap $B

1.296

Small

Exchange

XSHE - Shenzhen Stock Exchange

301166.SZ Stock Analysis

30

Uncovered

Shanghai Universal Biotech Co Ltd is uncovered by Eyestock quantitative analysis.

Rating

To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.

5/100

Low score

Market cap $B

1.296

Dividend yield

4.59 %

Shares outstanding

86.667 B

Shanghai Universal Biotech Co., Ltd. engages in the provision of life science research services. The company is headquartered in Shanghai, Shanghai and currently employs 493 full-time employees. The company went IPO on 2021-12-28. The firm is also engaged in the supply of life science instruments and consumables and comprehensive technical services. The products supplied by the Company are mainly third-party brand products, supplemented by independent brand products. The life science reagents mainly include immunological reagents based on antibodies and antibody related reagents, as well as molecular biology reagents, cell biology reagents and biochemical reagents. The life science instruments and consumables include detection and analysis and sample preparation. The comprehensive technical services include experimental services, technical support services and other services.

View Section: Eyestock Rating